Sildenafil for Prevention of Cerebral Vasospasm

NCT01091870 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Absence of inclusion criteria

Conditions

Subarachnoid Hemorrhage
Cerebral Vasospasm
Rupture of Intracranial Aneurysm

Interventions

DRUG: Placebo
DRUG: Sildenafil Citrate, 25 mg, 3 times a day.
DRUG: Sildenafil Citrate 50 mg, 3 times a day

Sponsor

Hospital de Clinicas de Porto Alegre